Author:
Boisdron-Celle Michele,Capitain Olivier,Faroux Roger,Borg Christophe,Metges Jean Philippe,Galais Marie Pierre,Kaassis Mehdi,Bennouna Jaafar,Bouhier-Leporrier Karine,Francois Eric,Baumgaertner Isabelle,Guerin-Meyer Véronique,Cojocarasu Oana,Roemer-Becuwe Celia,Stampfli Claire,Rosenfeld Ludovic,Lecompte Thierry,Berger Virginie,Morel Alain,Gamelin Erick
Reference58 articles.
1. 5-fluorouracil: mechanisms of action and clinical strategies;Longley;Nat Rev Cancer,2003
2. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial;Andre;J Clin Oncol,2003
3. Dihydropyrimidine dehydrogenase: its role in 5fFluorouracil clinical toxicity and tumor resistance;Diasio;Clin Cancer Res,1999
4. Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy;Lee;Clin Adv Hematol Oncol,2004
5. Clinical implication of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-Fluorouracil-associated toxicity: identification of new mutations in the DPD gene;van Kuilenburg;Clin Cancer Res,2000
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献